J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg).
Olga P Nyssen,Ángeles Pérez-Aisa,Bojan Tepes,Manuel Castro-Fernandez,Juozas Kupcinskas,Laimas Virginijus Jonaitis,Luis Bujanda,Alfredo J. Lucendo,Natasa Brglez Jurecic,Jorge Perez-Lasala,Oleg Shvets,Galina Dmitrivna Fadeenko,José María Huguet,Zdenki Kikec,Dmitry S. Bordin,Irina Voynovan,Marcis Leja,José Carlos Machado,Miguel Areia,Luis Fernández-Salazar,Luis Rodrigo,S A Alekseenko,Jesus Barrio,Juan Ortuño,Monica Perona,Liudmila Vologzhanina,Pilar Mata Romero,Oleg Zaytsev,Theodore Rokkas,Sotirios D. Georgopoulos,Rinaldo Pellicano,György M. Buzás,Ines Modolell,Blas Jose Gomez Rodriguez,Ilkay Simsek,Cem Simsek,Marina Roldan Lafuente,Tatiana Ilchishina,Judith Gomez Camarero,Manuel Domínguez-Cajal,Vassiliki Ntouli,Natalia Nikolaevna Dekhnich,Perminder Phull,O. Nunez,Frode Lerang,Marino Venerito,Frederic Heluwaert,Ante Tonkic,Maria Caldas,Ignasi Puig,Francis Mégraud,Colm O'Morain,Javier P. Gisbert,Hp-EuReg Investigators +53 more
TL;DR: In this article, the authors assess the frequency, type, intensity, and duration of adverse events, and their impact on compliance, for the most frequently used treatments in the European Registry on Helicobacter pylori management.
Journal ArticleDOI
Monitorización de la tiopurina metiltransferasa y de los metabolitos tiopurínicos para optimizar el tratamiento con azatioprina en la enfermedad inflamatoria intestinal
TL;DR: Randomized trials comparing the routine strategy of AZA/6-MP dosing (based exclusively on the patient's weight) versus individualized monitoring (based on quantification of TPMP activity and/or thiopurine metabolites) are required before definitive conclusions on the most effective alternative can be drawn.
Journal ArticleDOI
Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones
Nanne K. H. de Boer,Vineet Ahuja,Sven Almer,Azhar Ansari,Rupa Banerjee,Murray L. Barclay,Jake Begun,Adriaan A. van Bodegraven,Jean-Frederic Colombel,David P. Epstein,Timothy H. Florin,Richard B. Gearry,Javier P. Gisbert,Rupert W. Leong,Chris J. J. Mulder,Markus F. Neurath,Graham L. Radford-Smith,Margien L. Seinen,Melek Simsek,Miles P. Sparrow +19 more
Journal ArticleDOI
Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative.
Ariel Beresniak,Peter Malfertheiner,Peter Malfertheiner,Francesco Franceschi,Francois Liebaert,Hocine Salhi,Javier P. Gisbert +6 more
TL;DR: Cost‐effectiveness simulation models might help to identify the optimal strategy for Helicobacter pylori management strategies in patients with dyspepsia.
Journal ArticleDOI
Guía de práctica clínica sobre el manejo del paciente con dispepsia. Actualización 2012
Javier P. Gisbert,Xavier Calvet,Juan Ferrándiz,Juan José Mascort,Pablo Alonso-Coello,Mercè Marzo +5 more
TL;DR: En esta GPC se revisan las posibles estrategias iniciales en el paciente con dispepsia no investigada, valorando the posible decision of iniciar o no un tratamiento empirico o of investigar the existencia of una lesion that justifique los sintomas.